Profile
Elisabeth M.
M.
Gardiner worked as a Director-Physiology Discovery at aTyr Pharma, Inc. and as a Principal at Kalypsys, Inc. She was also a Vice President-Discovery Biology at Kinnate Biopharma, Inc. from 2018 to 2020.
Gardiner served as VP-Translational Medicine & Patrick Simms at Aravive, Inc. from 2020 to 2022.
She holds a doctorate degree from the University of Wisconsin.
Former positions of Elisabeth M. M. Gardiner
| Companies | Position | End |
|---|---|---|
| ARAVIVE, INC. | Corporate Officer/Principal | 31/03/2022 |
| KINNATE BIOPHARMA INC. | Corporate Officer/Principal | 31/05/2020 |
Kalypsys, Inc.
 Kalypsys, Inc. Pharmaceuticals: MajorHealth Technology Kalypsys, Inc. discovered and developed novel, first-in-class therapeutic agents to address unmet medical needs in respiratory and inflammatory diseases. The firm advanced its proprietary lead program, a novel, non-corticosteroid small molecule formulated for intranasal delivery, into clinical proof of concept studies. The company was founded by Pratik Shah, Jeremy S. Caldwell, Randall W. King, Kevin D. Lustig, Peter G. Schultz and Robert Downs in 2001 and was headquartered in Solana Beach, CA. | Corporate Officer/Principal | - |
| ATYR PHARMA, INC. | Corporate Officer/Principal | - |
Training of Elisabeth M. M. Gardiner
| University of Wisconsin | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ATYR PHARMA, INC. | Health Technology |
| ARAVIVE, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Kalypsys, Inc.
Kalypsys, Inc. Pharmaceuticals: MajorHealth Technology Kalypsys, Inc. discovered and developed novel, first-in-class therapeutic agents to address unmet medical needs in respiratory and inflammatory diseases. The firm advanced its proprietary lead program, a novel, non-corticosteroid small molecule formulated for intranasal delivery, into clinical proof of concept studies. The company was founded by Pratik Shah, Jeremy S. Caldwell, Randall W. King, Kevin D. Lustig, Peter G. Schultz and Robert Downs in 2001 and was headquartered in Solana Beach, CA. | Health Technology |
Kinnate Biopharma, Inc.
 Kinnate Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Kinnate Biopharma, Inc. operates as a biopharmaceutical company engaged in the research and development of Kinnate Discovery Engine that targets genomic drivers of cancer. The company was founded by Stephen W. Kaldor and Eric A. Murphy in January 2018 and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Elisabeth M. M. Gardiner
